Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5

Journal

Hepatology International

Date Issued

2022

Author(s)

DOI

10.1007/s12072-022-10390-z

URI

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134740418&doi=10.1007%2fs12072-022-10390-z&partnerID=40&md5=d2b7c420789785130ef1b932233f7ac4

https://scholars.lib.ntu.edu.tw/handle/123456789/619208

SDGs

[SDGs]SDG3

Publisher

Springer

Type

Review